Founded
31 Dec 2003
Website
VCID: 107259
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases.Funding
Funding rounds
(1 Mar 2008)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
MedImmune Ventures Inc | United States | ||
|
NeuroVentures Capital LLC | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
New Enterprise Associates Inc | Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. | United States | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Alexandria Real Estate Equities Inc |
+1 (626) 578-0777 |
Series B |
|
Bay City Capital LLC |
+1 (415) 676-3830 |
N/A |
|
|
MedImmune Ventures Inc |
+1 (301) 398-4259 |
Series B |
|
|
NeuroVentures Capital LLC |
+1 (434) 297-1000 |
Series B |
|
|
New Enterprise Associates Inc Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. |
+1 (650) 854-9499 |
N/A |
|
Oxford Bioscience Partners IV LP |
N/A | |
|
Pappas Ventures |
N/A |